文献速递主动脉疾病

窄远端主动脉的解剖与临床特征及腹主动脉瘤腔内修复术后的意义

Anatomic and clinical characterization of the narrow distal aorta and implications after endovascular aneurysm repair.
PubMed 文献 · J Vasc Surg · 2018-05-22

基于GREAT多中心注册研究1055例腹主动脉瘤腔内修复患者的资料,对比窄主动脉分叉(<16 mm,117例)与标准分叉(938例)患者术后1年结局。窄分叉组1年全因死亡率低于标准分叉组,两组再干预率与内漏需再干预率无显著差异,窄分叉未与更高的肢体闭塞或内漏发生率相关。

要点

  • 窄主动脉分叉(<16 mm)患者女性比例更高(25.6% vs 15.1%,P=.004),近端瘤颈与入路血管更细。
  • 1年免于死亡在标准分叉组为92.1%,窄分叉组为99.1%;1年免于再干预分别为95.1%与92.8%。
  • 随访1年内两组均未报告支架扭结、移位、断裂、压缩或夹层。

核心结论

  • 使用EXCLUDER装置行腹主动脉瘤腔内修复术后1年,窄主动脉分叉组与标准分叉组结局相当,窄主动脉分叉未发现与更高的后期肢体闭塞或内漏发生率相关。
  • 女性患者更常存在窄主动脉分叉,并与近端瘤颈和入路血管更窄及更重的合并症负担相关。

研究设计与样本

  • 前瞻性收集多中心GREAT注册研究中1055例于2010年8月至2015年9月接受腹主动脉瘤腔内修复术患者的资料,其中窄主动脉分叉(定义为<16 mm)117例、标准分叉938例。
  • 分析30天与1年发病率、死亡率和再干预结局,并用Kaplan-Meier生存曲线分析免于死亡和免于再干预。

主要发现

  • 远端主动脉瘤颈平均直径在窄分叉组为12.4 mm、标准分叉组为25.3 mm(P<.001),窄分叉组近端主动脉瘤颈直径也显著更小(P<.001)。
  • 窄分叉组女性比例更高(25.6% vs 15.1%,P=.004),合并症负担更重,外科切开入路比例显著更高(P<.001)。
  • 两组手术存活率均为100%,30天死亡率与安全性结局相似,但随访至1年标准分叉组全因死亡率显著更高(P=.02)。
  • 1年免于死亡在标准分叉组为92.1%、窄分叉组为99.1%;1年免于再干预在标准分叉组为95.1%、窄分叉组为92.8%。
  • 随访1年内,标准分叉组24例(2.6%)与窄分叉组4例(3.4%)出现需再干预的内漏(P>.99),其中II型内漏分别占已处理内漏的72%与60%。

关键数值与推荐

  • 窄主动脉分叉定义为<16 mm。
  • 随访1年内,标准分叉组10例(1.0%)与窄分叉组2例(1.7%)出现闭塞/血栓事件(P=.54)。
  • 随访1年内两组均未报告支架扭结、移位、断裂、压缩或夹层,标准分叉组有1例发生胸主动脉瘤破裂。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The purpose of this analysis was to compare 1-year clinical outcomes after endovascular repair of abdominal aortic aneurysms with the EXCLUDER device in patients with standard and narrow aortic bifurcations (AOBs). METHODS: Data were prospectively collected from a 1055-participant subset of the multicenter Global Registry for Endovascular Aortic Treatment (GREAT) treated for abdominal aortic aneurysm repair between August 2010 and September 2015. There were 117 patients with a narrow AOB (NB; defined as <16 mm) and 938 patients with a standard bifurcation (SB). The 30-day and 1-year morbidity, mortality, and reintervention outcomes were analyzed, with Kaplan-Meier survival curve analysis conducted on freedom from mortality and freedom from reintervention. RESULTS: The mean distal aortic neck diameter was 12.4 mm in the NB cohort and 25.3 mm in the SB cohort (P < .001), with NB patients also exhibiting significantly smaller diameter proximal aortic necks (P < .001). Patients in the NB cohort were more often female (25.6% vs 15.1%; P = .004) and with more severe comorbidity burden. There was a significantly higher rate of surgical cutdown access in the NB cohort (P < .001). Procedural survival was 100% in both groups. The 30-day mortality and safety outcomes were similar; however, all-cause mortality was significantly higher in the SB cohort through 1 year (P = .02). The 1-year freedom from mortality was estimated as 92.1% in the SB cohort and 99.1% in the NB cohort. Freedom from reintervention was estimated as 95.1% in the SB cohort and 92.8% in the NB cohort at 1 year. Through 1-year follow-up, 24 SB patients (2.6%) and 4 NB patients (3.4%) exhibited an endoleak requiring reintervention (P > .99). Type II endoleaks represented 72% and 60% of treated endoleaks, respectively. Through 1 year, 10 SB patients (1.0%) and 2 NB patients (1.7%) exhibited occlusive/thrombotic events (P = .54). There were no reported instances of kinking, migration, fracture, compression, or dissection through 1 year in either cohort. One SB patient experienced thoracic aortic aneurysm rupture. CONCLUSIONS: The 1-year outcomes after endovascular aneurysm repair with the EXCLUDER device were comparable in the NB and SB cohorts. A narrow AOB was not found to be associated with a higher incidence of later limb occlusions or endoleaks. Female patients were disproportionately more likely to have a narrow AOB, which correlated with narrowed proximal necks and access vessels, and a more severe comorbidity burden.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Briggs C, Babrowski T, Skelly C, et al. Anatomic and clinical characterization of the narrow distal aorta and implications after endovascular aneurysm repair. J Vasc Surg. 2018. PMID: 29802041. doi:10.1016/j.jvs.2017.12.073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。